Clinical evaluation of antihistamine, HS-592, in seasonal and perennial allergic rhinitis.
D000293:Adolescent; D000328:Adult; D002648:Child; D004987:Ethers / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D006634:Histamine H1 Antagonists / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D011759:Pyrrolidines / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006255:Rhinitis, Allergic, Seasonal / Q000188:drug therapy*; D012621:Seasons
D004987:Ethers; D006634:Histamine H1 Antagonists; D011759:Pyrrolidines